The FDA announced the approval of the first breathalyzer test to detect the COVID-19 virus.
The InspectIR COVID-19 Breathalyzer identifies five organic compounds detecting the virus in a patients' breath, with test results returning in under three minutes, according to the organization.
The agency said that a test study of 2,409 people, which included both people with and without symptoms, produced a 99.3% rate of correctly identified negative tests.
According to the FDA, the test had a 91.2% of correctly identified positive test results.